Journal
DIABETES TECHNOLOGY & THERAPEUTICS
Volume 25, Issue 6, Pages 426-430Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/dia.2023.0005
Keywords
Insulin infusion site; Insulin infusion set; Failure; Insulin pump; Pump malfunction
Categories
Ask authors/readers for more resources
Insulin infusion site (IIS) failures are common in individuals with diabetes on insulin pump therapy and often go undetected until hyperglycemia occurs. These failures are associated with negative perceptions and may be prevented or detected sooner through additional measures.
Insulin infusion site (IIS) failures are a weakness in insulin pump therapy. We examined experience with IIS failures among U.S. individuals with diabetes on insulin pump through survey distributed to the T1D Exchange Online Community. Demographic factors, IIS characteristics, and diabetes-related perceptions were assessed by logistic regression to determine odds of higher (>= 1 per month) or lower (<1 per month) reported IIS failure frequency. IIS failures were common; 41.4% reported >= 1 per month. IIS failure is usually detected through development of hyperglycemia rather than pump alarm. No assessed demographic factor or IIS characteristic was predictive; however, higher odds of >= 1 failure per month were associated with feelings of burnout (odds ratios [OR] 1.489 [1.024, 2.165]) and considering pump discontinuation (OR 2.233 [1.455, 3.427]). IIS failures are frequent and unpredictable, typically require hyperglycemia for detection, and are associated with negative perceptions. More should be done toward preventing IIS failures and/or detecting them sooner.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available